ArticlePDF Available

Effects of lemon balm (Melissa officinalis) on behavioral deficits and memory impairment of rats surviving sepsis

Authors:
Vol. 11(8), pp. 153-160, 25 February, 2017
DOI: 10.5897/JMPR2016.6266
Article Number: 9325A2663135
ISSN 1996-0875
Copyright © 2017
Author(s) retain the copyright of this article
http://www.academicjournals.org/JMPR
Journal of Medicinal Plants Research
Full Length Research Paper
Effects of lemon balm (Melissa officinalis) on
behavioral deficits and memory impairment of rats
surviving sepsis
João Eudes Filho1, Dâmaris Silveira1, Aluízio Carlos Soares1, Fabiana Pirani Carneiro1,
Melissa Sousa de Assis1, Franco Batista Leite1, Niraldo Paulino2, Greice Maria Souza1,
Mônica Valero da Silva1, Stéphanie Marchiori1, Karla Amaral1, Nadyelle Targino de Melo1,
Vania Moraes Ferreira1*
1Universidade de Brasília, Campus Universitário Darcy Ribeiro, s/n, 70910-900, Brasília, DF, Brazil.
2Medical Lex Gestão de Informações e Cursos Ltda. Av. Desembargador Vitor Lima, 260, sala 908, Ed. Madson Center
- Trindade, 88040-400, Florianópolis, SC, Brazil.
Received 2 October, 2016; Accepted 22 February, 2017
Sepsis has become one of the most frequent causes of mortality in intensive care centres. So far, there
is no effective pharmacotherapy that can prevent or improve the neurological consequences and
enhance survival. The goal of this study is to investigate the neuroprotective effect of lemon balm
(Melissa officinalis) on behavioural dysfunctions produced in sepsis-surviving rats. Adult male rats
were subjected to caecal ligation and puncture and the control animals were submitted to the sham
operation. Lemon balm ethanolic extract or saline, given orally, was administered for one week after
surgery procedures. Locomotion, anxiety, depressive behaviour and memory were investigated. In the
elevated plus-maze (EPM), the percentage of open arm entries and open arm time was very significant
in the animals treated with lemon balm extract, similar to the diazepam response in sham-operated and
sepsis-surviving rats. Locomotion in open field tests and the enclosed arm entries in the EPM were not
significantly altered by treatments. In the forced swimming (FS) test, the extract was effective at
reducing the immobility time as that demonstrated by fluoxetine. In the step-down inhibitory avoidance
test, the extract eased the effects on memory of sepsis-surviving animals. Collectively, these results
demonstrate that lemon balm ethanolic extract could be used for the prevention of cognitive and mood-
related deficits that may be associated with sepsis sequelae.
Key words: Anxiety, depression, locomotion, Melissa officinalis, memory.
INTRODUCTION
Brain disorders are currently getting top priority among
the science target and the literature has shown the
behavioural problems associated with traumatic brain
injury. Sepsis is an example of this damage and it is
characterized by a systemic inflammatory response and
is associated with high mortality in humans (Greenberg et
al., 2014). The main reason of death in septic patients
could be encephalopathy (Mazeraud et al., 2016; Tauber
154 J. Med. Plants Res.
et al., 2017). Nowadays, several studies are conducted to
evaluate the damage to the brain during sepsis and its
behavioural consequences, especially involving cognitive
and mood impairments present in sepsis survivors
(Comim et al., 2016; Leite et al., 2013; Mazeraud et al.,
2016; Tauber et al., 2017). The polymicrobial sepsis
induced in rats by caecal ligation and perforation (CLP)
experimental models are important because they
reproduce human sepsis consequences (Leite et al.,
2013), which is clinically relevant for elucidating new
therapy alternatives for this health problem (Hutchins et
al., 2014).
Traditional medicine was used on people before the
great development of modern medicine, based on
multiple alternatives of natural products to treat several
physiological dysfunctions. Research into the historical
literature has demonstrated that some of the natural
products and/or their pharmacologically active principles
have a broad spectrum of biological activities, including
central nervous system (CNS) properties (Andrade et al.,
2016; Bu et al., 2016).
Piper nigrum L. (Piperaceae) used in traditional
medicine of many countries, for example, has different
properties, such as antiinflammatory, antioxidant,
antidepressant and cognitive effects. The methanolic
extract of their fruits in beta-amyloid rat model of
Alzheimer's disease significantly exhibited anxiolytic- and
antidepressant-like effects and also antioxidant potential
(Hritcu et al., 2015). Acute treatment of rats with Lindera
obtusiloba extracts, commonly used as an alternative
medicine in Korea, significantly reduced immobility time
and increased swimming time, suggesting that the
antidepressant-like effects of this extracts were likely
mediated via the glucocorticoid receptor (Lim et al.,
2016). In addition, other neuroprotective efficacy could be
observed in in vivo and in vitro experiments (Jalsrai et al.,
2016).
Melissa officinalis is a medicinal plant from the
Lamiaceae family that has been used as a folk medicine
to threat central nervous disorders (Anheyer et al., 2017;
Kennedy et al., 2002). This plant has neuroprotective
activity at CNS because it displays potent antioxidant
activity (Soodi et al., 2017). From the phytochemical point
of view, the main chemical principles of this species of
herbal medicine are flavonoids, alkaloids, phenolic acids
and tannins (Noguchi-Shinohara et al., 2015; Shakeri et
al., 2016). These compounds may contribute to the
homeostasis of the CNS, especially because they can
protect against neurodegeneration and/or behavioural
disorders that can be correlated to dementia or traumatic
brain injury. Notably, it has also been reported as
lowering excitability, cognitive dysfunctions, stress and
anxiety levels in rodent models and humans (Anheyer et
al., 2017; Lin et al., 2015; Ross, 2015; Shakeri et al.,
2016). Previous results from our lab showed that the oral
intake of lemon balm EE for about 10 days has anxiolytic
and antidepressantlike properties in a manner gender
(male vs. female) dependent, particularly with regard to
the effective dose for each exposure length (Taiwo et al.,
2012).
Despite great availability of information regarding the
neuroprotective effects of plant extracts, the options for
sepsis treatment is scarce. In this context, the goal of this
work is to verify the possible neuroprotective action of
lemon balm extract on behavioural and cognitive deficits
due to sepsis sequela in rats.
MATERIALS AND METHODS
Animals
Male Wistar rats (n= 60), 3 months old, 350 g, from the animal
facility of Sena Aires Faculty (Valparaíso de Goiás-GO, Brazil),
were housed 5 to a cage with food and water available ad libitum
and were maintained on a 12-h light/dark cycle (lights on at 7:00
am) at room temperature (23 ± 1°C). The animals were allowed to
adapt to the laboratory conditions for at least 1 week before the
behavioural assessment. All procedures used in the present study
complied with the guidelines on animal care of the UNB Ethics
Committee on the Use of Animals, which follows the “Principles of
laboratory animal care”. Subjects were transferred in their cages to
the experimental room on the day of being tested, where they were
left unbothered to habituate for at least 1 h before the behavioural
tests.
Preparation of the plant extract
Dried leaves of M. officinalis were kindly supplied by Centroflora
Group (Botucatu, Brazil), who also provided a certification of the
plant’s identity and quality. Powdered plant material (1900 g) was
extracted by maceration at room temperature (24±3°C) using
ethanol as solvent. Following removal of the solvent, under vacuum
conditions and below 40°C using a Heildolph system (Heildolph ®
Instruments, Germany) composed by a rotavapor coupled to a
vacuum pump D-91126, and chiller a MX07R-20HD2E. After
solvent elimination, the crude ethanolic extract (EE) that was
obtained (13% yield) was then stored at -18°C.
Drugs and pharmacological procedures
Lemon balm EE (100 mg/kg) was dissolved in a solution containing
150 µL of Tween 80, 150 µL of ethanol and 150 µL of
Dimethylsulfoxide (DMSO). All these substances (except EE) were
obtained from Sigma Aldrich, Brazil. Each resulting preparation was
then suspended in 0.9% physiological saline. An equivalent
*Corresponding author. E-mail: vmmf@unb.br. Tel: + 55 61 8122 0005.
Author(s) agree that this article remain permanently open access under the terms of the Creative Commons Attribution
License 4.0 International License
preparation of Tween/alcohol/DMSO/saline (this mixture was used
to avoid fluid overload, swelling, acidosis and high blood sodium,
and to produce the best dilution of the drugs. Saline was used to
dilute other medications to be given by injection) was used as
vehicle control. These solutions were prepared 24 h prior to being
administered via oral gavage, in a volume of 1 mL/kg, having been
stored at 4C. Diazepam (1 mg/kg; DZP; Roche, Brazil) and
fluoxetine (10 mg/kg; FXT; Bluepharma, Brazil) were suspended in
distilled water containing 2% Tween 80 and physiological saline
(DMSO is not necessary in this solution, only for lemon balm EE
due to the product consistency), respectively. Both drugs were
prepared on the same day as being administered by gavage, in a
volume of 1 mL/kg. Lemon balm EE dose selection was based on
previous study published elsewhere (Kennedy et al., 2002). The
doses of the other substances varied according to the
pharmaceutical efficacy of each of them, in accordance with clinical
practice.
Caecal ligation and perforation surgery
Rats were weighed and anesthetized with a mixture of ketamine (80
mg/kg) and xylazine (10 mg/kg), given intraperitoneally. A 2-cm
midline laparotomy was performed to allow exposure of the caecum
to the adjoining intestine. The caecum was tightly ligated 5 times
with a 4.0-silk suture (Bioline, Brazil) at its base, below the
ileocaecal valve, and it was perforated five times through-and-
through with a 14-gauge needle (BD, Brazil). The caecum was then
gently squeezed to extrude a small amount of faeces from the
perforation site, returned to the peritoneal cavity, and the
laparotomy was closed with 4.0 silk sutures. The sham-operated
rats were submitted to all surgical procedures previously described
but the caecum was not perforated. To reproduce the protocol used
in surgery procedures on humans, all animals received saline
immediately after surgery procedures (50 mL/kg subcutaneous). A
mixture of ceftriaxone (30 mg/kg) + clindamycin (25 mg/kg) was
administered by intraperitoneal route (i.p.) every 12 h for 3 days.
They were kept in groups of 5 animals per cage with free access to
food and water, according to the procedure performed elsewhere
(Leite et al., 2013).
Treatment protocols
The animals were classified into 2 groups: the sham-operated
group and the sepsis group. Each one was divided into 3
subgroups to receive by oral route the control solution (saline);
diazepam (1 mg/kg) or fluoxetine (10 mg/kg), as positive controls;
or lemon balm EE (100 mg/kg). Animals received daily treatments
for 7 days and they were tested one hour after the seventh
administration. On the test day, one hour after treatment, the
animals were subjected to the behavioural tests. The doses chosen
in these protocols were based on the literature or previous
experiments from the laboratory.
Experimental procedures
Open field test
To evaluate locomotor activity, animals were tested in an open field
(OF), consisting of a wooden square box (60 x 60 x 35 cm) divided
into nine equal squares (20 x 20 cm). Each animal was placed in
the centre of the field and left to explore freely for 5 min. The
number of quadrants crossed with all four paws was used as a
measure of locomotion. After each trial, the apparatus was cleaned
Filho et al. 155
with ethanolic solution (10% v/v).
Elevated plus-maze test
Measures of anxiety were obtained in the elevated plus-maze
(EPM) test. This apparatus is made of wood, comprised of two
opposing open arms (50 x 10 cm) and two opposing closed arms
(50 x 10 x 40 cm), interconnected by a common central platform (10
x 10 cm). The entire apparatus was elevated 50 cm above floor
level, but to prevent falls, both open arms had a 1 cm high
plexiglass edge. The animal was placed on the central platform,
facing an enclosed arm, and allowed to explore the maze freely for
5 min. The following parameters were scored: number of open and
enclosed arm entries, time spent in the central platform, open and
enclosed arms. These were used to calculate the percentages of
open arm entries (%OAE) and open arm time (%OAT). Arm entry
was defined as all four paws in a specific arm (Pellow et al., 1985).
After each trial, the EPM was cleaned with ethanolic solution (10%
v/v).
Forced swimming test
The forced swimming (FS) test was used, modified from that
described by Porsolt et al. (1977). The animal was placed, for 5
min, in a glass cylinder (30 cm in diameter and 50 cm height)
containing 40 cm of water at 23±1°C, which forced the rat to swim
or float as its hind limbs were unable to touch the bottom. Time
spent immobile was recorded only during the last 3 min. Immobility
was scored whenever the animal stopped swimming and floated,
making only the small limb movements necessary to keep its head
above water level. After 5 min, the animal was removed from the
apparatus and dried.
Step-down inhibitory avoidance test
The inhibitory avoidance apparatus (Insight, Brazil) is to evaluate
aversive memory. It consisted of an acrylic box (50 × 25 × 25 cm),
whose floor was made of parallel stainless-steel bars (1 mm
diameter) spaced 1 cm apart. A platform (7 cm wide × 2.5 cm high)
was placed on the floor against the left wall. The animals were
placed on the platform and their latency in stepping down on the
grid with all four paws was measured with an automatic device. The
animals were submitted to the inhibitory avoidance task using a
protocol similar to that described previously (Lucena et al., 2013).
During training sessions, immediately after stepping down on the
grid, the animals received a 0.4-mA, 1.0-s (controlled by a monitor
attached to the equipment) scrambled foot shock. During test
sessions, no foot shock was administered and the step-down
latency (maximum 180 s) was used as the measure of retention.
The animals were submitted to a single training session.
In order to evaluate memory, test sessions were performed 1.5 h
after training. The administration of the extract or control solution
was performed by oral route 1 h before the training in the inhibitory
avoidance apparatus.
Statistical analysis
Data were expressed as means ± mean standard error (s.e.m.) of
10 animals and were analysed using one-way analysis of variance
(ANOVA) followed by Tukey's test. Data on the inhibitory avoidance
test are shown as median (interquartile range) of step-down
latencies. Comparisons of test session step-down latencies
156 J. Med. Plants Res.
Figure 1. Effects of oral subchronic administration of
saline (SAL), diazepam (DZP) and Melissa officinalis
ethanolic extract (100 mg/kg) on the percentage of open
arm entries (A), on the percentage of open time spent (B)
and on the number of enclosed arm entries (C) in the
elevated plus-maze test on sham-operated and sepsis-
surviving rats. Each bar represents the mean ± S.E.M. of
10 animals per group. *p0.05 as compared to the saline
treatment of the SHAM group; #p0.05 as compared to
the SEPSIS group (ANOVA, Tukey’s test).
between groups were performed with the KruskalWallis test
followed by the Mann-Whitney test. Data were analysed by Graph
Pad Instat® (GraphPad software, San Diego, CA). P-values lower
than 0.05 (P<0.05) were considered statistically significant.
RESULTS
In the EPM, sham-operated rats that had been exposed
to lemon balm EE showed enhanced percentage of open
arm entries (Figure 1A): [F(5,59) = 5.00, p<0.05] and
percentage of open arm time (Figure 1B): [F(5.59) = 4.20,
p<0.05], similar to the animals treated with DZP: % open
arm entries (Figure 1A): [F(5.59) =5.06, p<0.05] and %
open arm time (Figure 1B): [F(5,59) = 4.91, p<0.05]. In the
sepsis-surviving rats, the extract also enhanced the
percentage of open arm entries (Figure 1A): [F(5.59) =
5.91, p<0.05] and the percentage of open arm time
(Figure 1B): [F(5.59) = 5.07, p<0.05], similar to the animals
treated with DZP: % open arm entries (Figure 1A): [F(5.59)
=5.96, p<0.05] and % open arm time (Figure 1B): [F(5.59) =
5.00, p<0.05]. The frequency of enclosed arm entries
(Figure 2C) in the EPM as well as the number of
quadrants crossed in the open field test (Figure 2) were
not affected by any treatment and remained constant
between groups.
As shown in Figure 3B, FXT treatment was able to
reduce the immobility time in sham-operated ([F(5.59) =
3.96, p<0.05]) and sepsis-surviving rats ([F(5.59) = 3.21,
p<0.05]) as compared to the group that received the
control solution in each group. Lemon balm EE in sepsis-
surviving rats modified the immobility time only in the
sepsis groups ([F(5.59) = 5.37, p<0.05]).
As shown in Figure 4, the Kruskal-Wallis test followed
by the Mann-Whitney test revealed that the lemon balm
EE administration was able to improve the memory-
facilitating effect produced by sepsis-surviving rats in the
model of the step-down inhibitory avoidance test when
measuring short- ([H(4, N=31) = 27.10, p<0.0001]) and
long-term memory -([H(4, N=31) = 24.80, p<0.0001]).
DISCUSSION
Lemon balm EE was effective in reducing anxiety,
depression and cognitive impairment levels produced by
sepsis in rodents, showing a property independent of any
sedative effect as demonstrated by no interference in
locomotion in the open field test and frequency of
enclosed arm entries in the EPM, as demonstrated by
Figures 1 to 4. Most of the time, the phytomedicine
showed a similar effect with the positive controls DZP
and FXT, suggesting that the interference in GABA and
5-HT receptors by this extract may be a new alternative
for treating neurological dysfunctions produced by sepsis.
Anxiety and depression are the most prevalent mental
disorders arising among child, adolescent and adult
patients. Both psychiatric illnesses demonstrate marked
overlap and co-occurrence (Freeman et al., 2002).
Despite this, the prevalence of anxiety is 15 to 25% and
the prevalence of depression appears to be higher than
50% (Brown et al., 2001; Lewinsohn et al., 1997). These
two disorders may share the same or different
vulnerability factors even though anxiety disorders may
represent causal risk factors for the development of
depression (Goes, 2015; Starr et al., 2014).
0
20
40
60
*
*
**
A##
% Open arm entries
0
10
20
30
40
*
*
**
B
##
% Open arm time
DZP
DZP
0
2
4
6
8
10
SHAM
C
SEPSIS
Enclosed arm entries
Open arm entries (%)
Open arm time (%)
Filho et al. 157
Figure 2. Effects of oral subchronic administration of saline (SAL), diazepam
(DZP) and M. officinalis ethanolic extract (100 mg/kg) on the number of
quadrants crossed in open field test in sham-operated and sepsis-surviving
rats. Each bar represents the mean ± S.E.M. of 10 animals per group.
Figure 3. Effects of oral subchronic administration of saline (SAL), fluoxetine
(FXT) and Melissa officinalis ethanolic extract (100 mg/kg) on the immobile
time (in seconds) evaluated in the forced swimming test in sham-operated and
sepsis-surviving rats. Each bar represents the mean ± S.E.M. of 10 animals
per group. *p0.05 as compared to the saline treatment of the SHAM group;
#p0.05 as compared to the FXT group (ANOVA, Tukey’s test).
In the context of actual research, it was noted that the
sepsis-surviving rats showed suggestive anxiety behaviour
that was observed by reduction in the percentage of open
arm entries and the time spent in those arms in the EPM,
characterizing anxiogenic response. Those rats receiving
lemon balm EE maintained a similar response to the
0
20
40
60
80
SAL DZP M100 SAL DZP M100
SHAM SEPSIS
Locomotion
SAL
FXT
M100
SAL
FXT
M100
0
20
40
60
80
SHAM SEPSIS
**
#
#
Immobility (sec)
158 J. Med. Plants Res.
Figure 4. Effects of oral subchronic administration of saline (SAL) and
Melissa officinalis ethanolic extract (100 mg/kg) on short- (A) and long-
term memory (B) in the step-down inhibitory avoidance test in sham-
operated and sepsis-surviving rats. Data are shown as the median
(interquartile ranges) of 10 animals. *p<0.05 as compared to the saline
treatment of the respective group (Kruskall Wallis - Mann Whitney).
sham animals. As regards the assessment of depression,
the animals showed increased immobility time in the
forced swimming test, which was reduced by FXT and
the lemon balm EE. These anxiolytic and antidepressant
results were not due to either hypoactivity or hyperactivity
displayed by animals, since their locomotion was not
changed in the open field test and the entries in the
enclosed arms in the EPM.
The observed anxiolytic effect of this natural product is
congruent with data obtained elsewhere (Kennedy et al.,
2006). The results are supported by the fact that rodents
normally exhibit a preference for the enclosed arms and
avoidance of the open arms of the EPM. Anxiolytic drugs,
such as DZP, modulate EPM behaviour in rodents,
causing an increase in the percentage of entries and time
spent in the open arms of the maze. Therefore, these
measures can serve as an index of anxiety (Horii and
Kawaguchi, 2015).
Thus, our results are in accordance with previous data,
showing anxiogenic and depressive responses in sepsis-
surviving rats. Leite et al. (2013) observed that repeated
nicotine administration does not alter the survival rate in
rats subjected to caecal ligation and puncture and they
provide new evidence that nicotine can improve long-
lasting memory impairment and anxiogenic-like responses
in sepsis-surviving animals. Tuon et al. (2007), in turn,
demonstrated in sepsis-surviving rats, a significant
increase in the immobility time as compared to the sham-
operated rats. The imipramine was able to reduce this
evaluated parameter, with no locomotion impairment. In
0
30
60
90
120
150
180
*
*
A
Latency (sec)
SAL
M100
SAL
M100
0
30
60
90
120
150
180
**
B
SHAM SEPSIS
Latency (sec)
the experiments, the FXT, a selective serotonin reuptake
inhibitor, showed similar results.
Lemon balm is known for its mild sedative properties
(Anheyer et al., 2017), even following a single
administration (Soulimani et al., 1991). In our study, such
behaviour was not observed. The fact that the lemon
balm EE and DZP did not generally alter quadrant
crossings and enclosed arm entry in the sham and EPM
tests, respectively, suggests that the psychoactive effects
observed in the present study may not be due to changes
in the animals’ locomotor patterns.
Regarding the cognitive aspect, animals that survived
the sepsis showed a loss of short- and long-term
memory, which was characterized by the decrease in
length of time spent in the inhibitory avoidance platform.
The administration of lemon balm EE made the animals
spend more time on the platform, characteristic behaviour
of memory retention.
Several studies have recently shown the importance of
phytotherapies for treating behavioural dysfunctions and
cognitive problems in humans (Anheyer et al., 2017;
Kennedy et al., 2002; Ross, 2015), even though there is
little information about the possible pharmacodynamics
involved in the pharmacological effects. For M. officinalis,
it is well documented that its effects could be related to
the active components that have been identified as
monoterpenoid aldehydes, monoterpene glycosides,
flavonoids and polyphenolic constituents (Shakeri et al.,
2016; Wightman, 2017).
Substantial progress has been made in our
understanding of how some herbal medicines can
ameliorate behavioural and cognitive processes in
patients with different neurological impairments. As
previously mentioned, nature has sources for various
types of treatment, providing effective antimicrobials to
treat infections caused by bacteria, viruses and fungi,
while offering therapeutic support to multiple organs and
body systems. On account of this, in this present
research, we also do not rule out the possibility that
lemons balm EE have interfered in aspects directly
related to inflammation, since it possesses potential anti-
inflammatory activities, supporting the traditional
application of this plant in treating various diseases
associated with inflammation and pain in more peripheral
areas (Bounihi et al., 2013) and brain areas, whose
active principles can probably be carried through the
cerebral blood flow and interact with several
neurotransmitters and signalling pathways involving
kinase enzymes (Wightman, 2017).
Conclusion
Although, there is a wide variety of a drug to treat
microbial infections, it is important to consider the
frequency and severity of adverse effects. Moreover, as
Filho et al. 159
the arsenal of available antibiotics in the pharmaceutical
market is increasingly being depleted due to microbial
resistance, there is a need for more alternative and less
toxic treatments. Thus, considering the results obtained
here, it is possible to suggest that the extract from lemon
balm can be considered a potential alternative for the
treatment of diseases, which have similar (or no similar)
reliability as conventional drugs DZP and FLX.
CONFLICTS OF INTERESTS
The authors have not declared any conflict of interests.
ACKNOWLEDGEMENTS
The authors thank MSc Elizabeth Tèran (in memorian)
from Centroflora (Ourinhos, Brazil) for generously
providing the Melissa officinalis extract used in this study.
They are also grateful to Sena Aires Faculty for providing
the experimental animals used in this study.
REFERENCES
Andrade PB, Grosso C, Valentão P, Bernardo J (2016). Flavonoids in
Neurodegeneration: Limitations and Strategies to Cross CNS
Barriers. Curr. Med. Chem. 23(36):4151-4174.
Anheyer D, Lauche R, Schumann D, Dobos G, Cramer H (2017).
Herbal medicines in children with attention deficit hyperactivity
disorder (ADHD): A systematic review. Complement. Ther. Med.
30:14-23.
Bounihi A, Hajjaj G, Alnamer R, Cherrah Y, Zellou A (2013). In Vivo
Potential Anti-Inflammatory Activity of Melissa officinalis L. Essential
Oil. Adv. Pharmacol. Sci. 2013:101759.
Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB (2001).
Current and lifetime comorbidity of the DSM-IV anxiety and mood
disorders in a large clinical sample. J. Abnorm. Psychol. 110:585-
599.
Bu XL, Rao PP, Wang YJ (2016). Anti-amyloid Aggregation Activity of
Natural Compounds: Implications for Alzheimer's Drug Discovery.
Mol. Neurobiol. 53(6):3565-3575.
Comim CM, Bussmann RM, Simão SR, Ventura L, Freiberger V,
Patrício JJ, Palmas D, Mendonça BP, Cassol-Jr OJ, Quevedo J
(2016). Experimental Neonatal Sepsis Causes Long-Term Cognitive
Impairment. Mol. Neurobiol. 53(9):5928-5934.
Freeman MP, Freeman SA, McElroy SL (2002). The comorbidity of
bipolar and anxiety disorders: prevalence, psychobiology, and
treatment issues. J. Affect. Disord. 68:1-23.
Goes FS (2015). The importance of anxiety states in bipolar disorder.
Curr. Psychiatry Rep. 17(2):3.
Greenberg JA, David MZ, Hall JB, Kress JP (2014). Immune
dysfunction prior to Staphylococcus aureus bacteremia Is a
determinant of long-term mortality. PLoS One 9(2):e88197.
Horii Y, Kawaguchi M (2015). Higher detection sensitivity of anxiolytic
effects of diazepam by ledge-free open arm with opaque walled
closed arm elevated plus maze in male rats. Behav. Brain Res.
294:131-140.
Hritcu L, Noumedem JA, Cioanca O, Hancianu M, Postu P, Mihasan M
(2015). Anxiolytic and antidepressant profile of the methanolic extract
of Piper nigrum fruits in beta-amyloid (1-42) rat model of Alzheimer's
disease. Behav. Brain Funct. 11:13.
Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A (2014). The new
160 J. Med. Plants Res.
normal: immunomodulatory agents against sepsis immune
suppression. Trends Mol. Med. 20(4):224-233.
Jalsrai A, Numakawa T, Kunugi H, Dieterich DC, Becker A (2016). The
neuroprotective effects and possible mechanism of action of a
methanol extract from Asparagus cochinchinensis: In vitro and in vivo
studies. Neuroscience 322:452-463.
Kennedy DO, Little W, Haskell CF, Scholey AB (2006). Anxiolytic effects
of a combination of Melissa officinalis and Valeriana officinalis during
laboratory induced stress. Phytother. Res. 20(2):96-102.
Kennedy DO, Scholey AB, Tildesley NTJ, Perry EK, Wesnes KA (2002).
Modulation of mood and cognitive performance following acute
administration of Melissa officinalis (lemon balm). Pharmacol.
Biochem. Behav. 72:953-964.
Leite FB, Prediger RD, Silva MV, de Sousa JB, Carneiro FP, Gasbarri
A, Tomaz C, Queiroz AJ, Martins NT, Ferreira VM (2013). Role of
nicotine on cognitive and behavioral deficits in sepsis-surviving rats.
Brain Res. 1507:74-82.
Lewinsohn PM, Zinbarg R, Seeley JR, Lewinsohn M, Sack WH (1997).
Lifetime comorbidity among anxiety disorders and between anxiety
disorders and other mental disorders in adolescents. J. Anxiety
Disord. 11:377-394.
Lim DW, Lee MS, Her S, Cho S, Lee CH, Kim IH, Han D (2016).
Antidepressant-Like Effects of Lindera obtusiloba Extracts on the
Immobility Behavior of Rats in the Forced Swim Test. Molecules
21(3):277.
Lin SH, Chou ML, Chen WC, Lai YS, Lu KH, Hao CW, Sheen LY (2015).
A medicinal herb, Melissa officinalis L. ameliorates depressive-like
behavior of rats in the forced swimming test via regulating the
serotonergic neurotransmitter. J. Ethnopharmacol. 175:266-272.
Lucena GM, Prediger RD, Silva MV, Santos SN, Silva JF, Santos AR,
Azevedo MS, Ferreira VM (2013). Ethanolic extract from bulbs of
Cipura paludosa reduced long-lasting learning and memory deficits
induced by prenatal methylmercury exposure in rats. Dev. Cogn.
Neurosci. 3:1-10.
Mazeraud A, Pascal Q, Verdonk F, Heming N, Chrétien F, Sharshar T
(2016). Neuroanatomy and physiology of brain dysfunction in sepsis.
Clin. Chest Med. 37(2):333-345.
Noguchi-Shinohara M, Ono K, Hamaguchi T, Iwasa K, Nagai T,
Kobayashi S, Nakamura H, Yamada M (2015). Pharmacokinetics,
Safety and Tolerability of Melissa officinalis Extract which Contained
Rosmarinic Acid in Healthy Individuals: A Randomized Controlled
Trial. PLoS One 10(5):e0126422.
Pellow S, Chopin P, File SE, Briley M (1985). Validation of open:closed
arm entries in an elevated plus-maze as a measure of anxiety in the
rat. J. Neurosci. Methods 14:149-167.
Porsolt RD, Lepichon M, Jalfre M (1977). Depresssion new animal-
model sensitive to antidepressant treatments. Nature 266:730-732.
Ross SM (2015). Valerian Root and Lemon Balm Extracts: A
Phytomedicine Compound Improves Symptoms of Hyperactivity,
Attention Deficits, and Impulsivity in Children. Holist. Nurs. Pract.
29(6):391-395.
Shakeri A, Sahebkar A, Javadi B (2016). Melissa officinalis L. - A review
of its traditional uses, phytochemistry and pharmacology. J.
Ethnopharmacol. 188:204-228.
Soodi M, Dashti A, Hajimehdipoor H, Akbari S, Ataei N (2017). Melissa
officinalis Acidic Fraction Protects Cultured Cerebellar Granule
Neurons Against Beta Amyloid-Induced Apoptosis and Oxidative
Stress. Cell J. 18(4):556-564.
Soulimani R, Fleurentin J, Mortier F, Misslin R, Derrieu G, Pelt JM
(1991). Neurotropic action of the hydroalcoholic extract of Melissa
officinalis in the mouse. Planta Med. 57:105-109.
Starr LR, Hammen C, Connolly NP, Brennan PA (2014). Does relational
dysfunction mediate the association between anxiety disorders and
later depression? Testing an interpersonal model of comorbidity.
Depress Anxiety 31(1):77-86.
Taiwo AE, Leite FB, Lucena GM, Barros M, Silveira D, Silva MV,
Ferreira VM (2012). Anxiolytic and antidepressant-like effects of
Melissa officinalis (lemon balm) extract in rats: Influence of
administration and gender. Indian J. Pharmacol. 44:189-192.
Tauber SC, Eiffert H, Brück W, Nau R (2017). Septic encephalopathy
and septic encephalitis. Expert Rev. Anti-Infect. Ther. 15(2):121-132.
Tuon L, Comim CM, Antunes MM, Constantino LS, Machado RA,
Izquierdo I, Quevedo J, Dal-Pizzol F (2007). Imipramine reverses the
depressive symptoms in sepsis-surviving rats. Inten. Care Med.
33:2165-2167.
Wightman EL (2017). Potential benefits of phytochemicals against
Alzheimer's disease. Proc. Nutr. Soc. 1:1-7.
... Caecal ligation and perforation surgery. The animals were subjected to Caecal ligation and perforation (CLP) as previously described [21][22][23]. Briefly, rats were anaesthetized with a mixture of ketamine (80 mg/kg) and xylazine (10 mg/kg), given intraperitoneally. ...
... The behavioural tests were conducted in independent groups of animals by an experienced experimenter who was unaware of the experimental group of the animals tested. After each trial, the apparatus was cleaned with ethanol solution (10% v/v) and dried with paper towels to avoid odour impregnation [21][22][23]. ...
... Immediately after the animal was placed in the centre of the arena, its movements were scored. Locomotor activity was considered only when the animal placed its four paws into one square [21][22][23]. ...
Article
There are many studies that have sought to find drug therapies to prevent harm arising from sepsis. Such studies have represented a progress in the support to septic patients and also in the development of new pharmacological alternatives. Our interest was to investigate the caffeine effect on sepsis behavioural and memory impairments. Male rats were anaesthetized and the surgery was made to allow exposure of the cecum, which was then squeezed to extrude a small amount of faeces from the perforation site, which was later placed back into the peritoneal cavity. This procedure, which served to generate experimental sepsis, is herein referred to as ceccum ligation and perforation (CLP). The caffeine (10 mg/kg) was administered by gavage route, once daily, during 7 or 14 consecutive days to investigate the effects of acute or subchronic caffeine treatment on long‐term behavioural and cognitive deficits induced by CLP. On the last day, one hour after caffeine administration, the animals were submitted to open‐field, elevated plus‐maze (EPM), forced swimming, and step‐down inhibitory avoidance tests. The results showed that caffeine increased the percentage of open arm entries and open arm time in the EPM test, and reduced the immobility time when compared to the sham‐operated group. The caffeine also increased the latency in the inhibitory avoidance test platform. Our results demonstrated that the caffeine improved behavioural changes and improved the neurocognitive deficits of sepsis‐surviving animals. It is possible that blockage of the adenosine receptors may be responsible for the results here observed. This article is protected by copyright. All rights reserved.
... This is in agreement with other findings in which the oral administration of MO was shown to have no profound effect on locomotor activity. 32,33 The MPAJ, on the other hand, did reduce the locomotor activity after i.p. injection of the extract at 12.5 mg/kg. No one before has studied the acute effect of MPAJ after i.p. administration on locomotor activity. ...
Article
Full-text available
Objective The present study investigates the hypnotic action of the methanolic partition of Albizia julibrissin (MPAJ) and various partitions (total, ethyl acetate, and aqueous) of Melissa officinalis (MO) in mice. Methods Pentobarbital‐induced sleep (PIS) time prolongation was used to assess the hypnotic action of test compounds. For the tolerance study, MO and MPAJ were given alone or in combination for 7 days, and then the locomotor activity of the mice was measured as an index of tolerance. Mortality of the herbal extracts was studied after intraperitoneal (i.p.) and oral administration in mice. Results Separate administration of total extracts of Melissa officinalis and methanolic extract of Albizia julibrissin at 12.5 mg/kg significantly increased the PIS time. In the combination of two plants, there was no additional or synergistic increase in sleepiness when compared to the separate administration of each plant (p < 0.05). In contrast to diazepam, the locomotor activity of the animals was not significantly altered after 7 days of injection with MPAJ or total extract of MO (TEMO), or their combinations. Conclusion Separate administration of TEMO and MPAJ provides significant hypnotic effects. The combination of two extracts, however, does not result in synergistic or additive hypnotic action. The lack of additive effects could be due to possible interaction by components of the two plants. The increase in mortality rate and undesirable reactions observed after i.p. administration of MPAJ is probably due to the absorption of certain toxic compounds that are not normally absorbed after oral administration.
... Enzymatic inhibition of the above-mentioned enzymes leads to alleviation of depression symptoms. Research also suggests that Melissa officinalis produces protective effects in the PC12 cell line and protects neurons from oxidative stress [75]. decreases the enzymatic leakage of lactate dehydrogenase, preserves cellular morphology, restores superoxide dismutase, and catalyses enzyme levels, thereby preventing neuronal damage [77]. ...
Article
Full-text available
The strategies involved in the development of therapeutics for neurodegenerative disorders are very complex and challenging due to the existence of the blood-brain barrier (BBB), a closely spaced network of blood vessels and endothelial cells that functions to prevent the entry of unwanted substances in the brain. The emergence and advancement of nanotechnology shows favourable prospects to overcome this phenomenon. Engineered nanoparticles conjugated with drug moieties and imaging agents that have dimensions between 1 and 100 nm could potentially be used to ensure enhanced efficacy, cellular uptake, specific transport, and delivery of specific molecules to the brain, owing to their modified physico-chemical features. The conjugates of nanoparticles and medicinal plants, or their components known as nano phytomedicine, have been gaining significance lately in the development of novel neuro-therapeutics owing to their natural abundance, promising targeted delivery to the brain, and lesser potential to show adverse effects. In the present review, the promising application, and recent trends of combined nanotechnology and phytomedicine for the treatment of neurological disorders (ND) as compared to conventional therapies, have been addressed. Nanotechnology-based efforts performed in bioinformatics for early diagnosis as well as futuristic precision medicine in ND have also been discussed in the context of computational approach.
... Research showed that M. officinalis has medicinal compounds which could be used to treat different illnesses. Activities like antioxidant, anti-mutagen, anti-inflammatory, anti-hyperglycemic, and memory impairment are some of the biologically important functions, which have been proven in several experimental methods (Hasanein and Riahi 2015;Noguchi-Shinohara et al. 2015;Eudes Filho et al. 2017;Jahanban-Esfahlan et al. 2017). ...
Article
Nanoparticles are receiving many interests due to their broad efficiency in mitigating environmental stresses. The purpose of this research was to study the potential of selenium-nanoparticles (Se-NPs) to mitigate the adverse effects of salt stress on growth, physiology, and gene expression of Melissa officinalis. The pot experiment was conducted in a factorial based on completely randomized design (CRD) with three Se-NPs concentrations (0, 50, and 100 mg L−1) and four salinity levels (0, 50, 100, and 150 mM NaCl). The foliar spray of Se-NPs improved the growth of M. officinalis plants at different salinity concentrations, from which the most effective was 50 mg L−1. Plant growth decreased by progressing salinity concentration so that the minimum growth was observed at 150 mM NaCl. The Se-NPs improved salt tolerance in M. officinalis by decreasing lipid peroxidation through increased activity of antioxidant enzymes viz. superoxide dismutase (SOD), catalase (CAT), and peroxidase (POX). Furthermore, exposure to Se-NPs enhanced the transcript levels of phenylalanine ammonia-lyase and rosmarinic acid (RA) synthase genes in lemon balm plants under salt conditions. Plants treated with 100 mg L−1 Se-NPs at non-saline conditions revealed the highest RA accumulation. According to the findings, we suggest both 100 mg L−1 Se-NPs to alleviate the adverse effects of salinity on in the M. officinalis, as well as the biosynthesis pathway of RA as a valuable secondary metabolite.
... Research has suggested that the essential oil from M. officinalis enhances cell proliferation and neuroblast differentiation in hippocampus part of mouse brain by reduction in serum corticosterone levels as well as increase in GABA (gamma-amino butyric acid) neurotransmitter(Yoo et al. 2011). Lemon balm acts as a neuroprotective agent of cognitive and behavioral dysfunctions by inhibiting acetylcholinesterase enzyme (AChE)(Eudes et al. 2017;Zarei et al. 2015). The memory improving effects of the plant are also experimentally proved(Soodi et al. 2014). ...
Chapter
Presently, neurological disorders form a major proportion of non-communicable diseases. Their incidence has increased due to several factors such as lifestyle changes, changes in dietary patterns, and increased psychological stress. Due to increase in awareness regarding these disorders by health-care professionals and general public, increasing number of cases are diagnosed with every passing year. This presents a challenge, especially in under-developed and developing countries, where the public health-care systems are not well established and penetration of health insurance cover is relatively much lower. Alternative medicine has traditionally been used in several cultures around the world to treat neurological problems. Essential oils and other plant volatiles have a long history of traditional use for ameliorating symptoms of neurological and psychological disorders. Essential oils of lavender, rose, lemon balm, etc. have shown good promise. Further, modern research has validated some of the claims with regard to relieving of neural and psychological issues by plant VOCs. Some of these have been shown to modulate key enzymes that are targets for depression therapy. In the present chapter we have presented an overview of above, and toward the end we have attempted to identify lacunas in this area which may help to formulate future research strategies.
... The leaves of Melissa officinalis L. (Lamiaceae), also known as lemon balm, are used in traditional medicine for its nerve calming and spasmolytic effects. The leaves produce calming and soothing effects through GABAA benzodiazepine receptor [71]. Its extracts contain some compounds such as flavonoids such as quercitrin as well as apigenin, luteolin and phenolic acids. ...
Article
Full-text available
Neurodegeneration refers to a condition of neuronal death occurring as a result of progressive disease of long termand is becoming a major health problem in the 21st century. Neurons degenerated are not replaced resulting in cognitive loss ,many neurodegenerative disorders, such as schizophrenia, depression, Alzheimer's Disease (AD) dementia, cerebrovascular impairment, seizure disorders, head injury, Parkinsonism. Neuroprotection refers to the strategies and possible mechanisms that are able to protect the central nervous system (CNS) against neuronal injury and neurodegenerative disorders. The past decade has witnessed an intense interest in herbal plants having long-term health promoting or medicinal qualities. Comprehensive research and discovery has demonstrated that natural products, medicinal herbs, plant extracts, and their metabolites, have great potential as neuroprotective agent. Although the precise mechanisms of action of herbal drugs have yet to be determined, some of them have been shown to exert anti-inflammatory and/or antioxidant effects. Thus the herbal plants can be a valuable source of drug against neurodegenerative disorders which will require high-throughput screening. This review will highlight the role of herbal plants and their phytoconstituents against neurodegenerative diseases and other related disorders, focusing on their mechanism of action and therapeutic potential. Keywords:
Chapter
Sickle cell anemia (SCA) is an inherited disorder in the β-globin chain of hemoglobin that affects millions of people around the world, especially children. This disease prevalently occurs in some Mediterranean and Saharan Africa. For the treatment of SCA patients, a wide range of drugs have been explored by targeting antisickling activity, γ-globulin induction, antiplatelet effect, etc., but hardly a few drugs have shown potential to combat with this complex disease phenomenon. In spite of unprecedented advances in modern system of medicine, people in the disease-prone area have been taking traditional medicinal plants or plant-derived products to increase the life span of patients. Moreover, numerous clinical trials have been going on for the use of natural products under the purview of symptomatic management of SCA. This chapter is focused on the effect of natural products in pure form or characterized phytoconstituents on particularly inhibition of hemoglobin polymerization. This summarized information will be beneficial for further exploration of new therapeutics in the treatment arena of SCA.
Article
Full-text available
Our current therapeutic drugs for Alzheimer's disease are predominantly derived from the alkaloid class of plant phytochemicals. These drugs, such as galantamine and rivastigmine, attenuate the decline in the cholinergic system but, as the alkaloids occupy the most dangerous end of the phytochemical spectrum (indeed they function as feeding deterrents and poisons to other organisms within the plant itself), they are often associated with unpleasant side effects. In addition, these cholinesterase inhibiting alkaloids target only one system in a disorder, which is typified by multifactorial deficits. The present paper will look at the more benign terpene (such as Ginkgo biloba, Ginseng, Melissa officinalis (lemon balm) and Salvia lavandulaefolia (sage)) and phenolic (such as resveratrol) phytochemicals; arguing that they offer a safer alternative and that, as well as demonstrating efficacy in cholinesterase inhibition, these phytochemicals are able to target other salient systems such as cerebral blood flow, free radical scavenging, anti-inflammation, inhibition of amyloid-β neurotoxicity, glucoregulation and interaction with other neurotransmitters (such as γ-aminobutyric acid) and signalling pathways (e.g. via kinase enzymes).
Article
Full-text available
Objective Extracellular deposition of the beta-amyloid (Aβ) peptide, which is the main finding in the pathophysiology of Alzheimer’s disease (AD), leads to oxidative damage and apoptosis in neurons. Melissa officinalis (M. officinalis) is a medicinal plant from the Lamiaceae family that has neuroprotective activity. In the present study we have investigated the protective effect of the acidic fraction of M. officinalis on Aβ-induced oxidative stress and apoptosis in cultured cerebellar granule neurons (CGN). Additionally, we investigated a possible role of the nicotinic receptor. Materials and Methods This study was an in vitro experimental study performed on mice cultured CGNs. CGNs were pre-incubated with different concentrations of the acidic fraction of M. officinalis for 24 hours, followed by incubation with Aβ for an additional 48 hours. CGNs were also pre-incubated with the acidic fraction of M. officinalis and mecamylamin, followed by incubation with Aβ. We used the 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay to measure cell viability. Acetylcholinesterase (AChE) activity, reactive oxygen species (ROS) production, lipidperoxidation, and caspase-3 activity were measured after incubation. Hochst/annexin Vfluorescein isothiocyanate (FITC)/propidium iodide (PI) staining was performed to detect apoptotic cells. Results The acidic fraction could protect CGNs from Aβ-induced cytotoxicity. Mecamylamine did not abolish the protective effect of the acidic fraction. AChE activity, ROS production, lipid peroxidation, and caspase-3 activity increased after Aβ incubation. Preincubation with the acidic fraction of M. officinalis ameliorated these factors and decreased the number of apoptotic cells. Conclusion Our results indicated that the protective effect of the acidic fraction of M. officinalis was not mediated through nicotinic receptors. This fraction could protect CGNs through antioxidant and anti-apoptotic activities.
Article
Full-text available
Extracts of Asparagus cochinchinensis (AC) have antitumor, anti-inflammatory, and immunostimulant effects. The neurobiological mechanisms underlying the effects of AC have not been sufficiently explored. Thus we performed in vivo and in vitro experiments to further characterize potential therapeutic effects and to clarify the underlying mechanisms. In the tail suspension test immobility time was significantly reduced after administration of AC which suggests antidepressant-like activity without effect on body core temperature. Moreover, in animals pretreated with AC infarct size after occlusion of the middle cerebral artery was reduced. In vitro experiments confirmed neuroprotective effects. Total saponin obtained from AC significantly inhibited H2O2-induced cell death in cultured cortical neurons. The survival-promoting effect by AC saponins was partially blocked by inhibitors for extracellular signal-regulated kinase (ErK) and phosphoinositide 3-kinase Akt (PI3K/Akt) cascades, both of which are known as survival-promoting signaling molecules. Furthermore, phosphorylation of Scr homology-2 (SH2) domain-containing phosphatase 2 (Shp-2) was induced by AC, and the protective effect of AC was abolished by NSC87877, an inhibitor for Shp-2, suggesting an involvement of Shp-2 mediated intracellular signaling in AC saponins. Moreover, AC-induced activation of pShp-2 and ErK1/2 were blocked by NSC87877 indicating that activation of these signaling pathways was mediated by the Shp-2 signaling pathway. These effects appear to be associated with activation of the Shp-2, ErK1/2 and Akt signaling pathways. Our results suggest that AC has antidepressant-like and neuroprotective (reducing infarct size) effects and that activation of pShp-2 and pErK1/2 pathways may be involved in the effects.
Article
Introduction: During the last two decades, septic encephalopathy (SE) was recognized as a clinically relevant problem with a high prevalence in patients at admission and during their hospital stay. SE is a condition associated with increased mortality and morbidity such as long-term cognitive impairment. Areas covered: This review illustrates the pathophysiology of sepsis-associated encephalopathy and encephalitis involving blood-brain-barrier dysfunction and neuroinflammation caused by endothelial and microglial activation by endogenous or pathogen-derived compounds, hypoxia by impaired microvascular regulation and septic shock as well as imbalance of neurotransmitters. The continuum between septic-embolic and septic-metastatic encephalitis and SE is underlined by histological findings. The options of technical examinations and biomarkers to diagnose SE are discussed together with established therapeutic options as well as current experimental approaches. Expert commentary: An outlook for clinicians is provided including promising diagnostic approaches by means of new imaging techniques. Clinical trials with drugs already established for other indications such as statins, erythropoietin and minocycline are warranted in the future.
Article
Objective The purpose of this review is to identify evidence in herbal therapy in the treatment of ADHD concerning effectiveness and drug tolerability. Method For this Medline/PubMed, Scopus and the Cochrane Central Register of Controlled Trials (Central) were searched from their inception to 15 July 2016. Only randomized controlled trails (RCT) with children (0 to 18 years) suffering from ADHD were included in this review. Results Nine RCTs with 464 patients comparing herbal pharmaceuticals to placebo or active control were included. Seven different herbs were tested in the treatment of ADHD symptoms. Low evidence could be found for Melissa officinalis, Valeriana officinalis and Passiflora incarnata. Limited evidence could be found for pine bark extract and Gingko biloba. The other herbal preparations showed no efficacy in the treatment of ADHD symptoms. Conclusion While there is still a lack of sufficient numbers of RCTs no concrete recommendations for use can be made so far.
Article
The central nervous system (CNS) is a mythical target for drug delivery. There is an ongoing debate over the brain accessibility of flavonoids, a group of plant-derived secondary metabolites widely known by their multifarious bioactivities achieved by distinct mechanisms. Recently, their applicability in the management of neurologic and psychiatric disorders, such as Alzheimer's and Parkinson's diseases, and major depression, has received particular attention. To reach their target, flavonoids must cross over the ultimate obstacle - the blood-brain barrier - at pharmacologically effective concentrations. This review addresses the low brain-bioavailability issue, based on in vitro and in vivo evidences. Besides the lipophilic character of the flavonoids, their permeability will depend upon the role of membrane transporters, especially those from the ABC superfamily. The enzymatic elements, namely β-glucuronidase, can induce a transient deconjugation process and affect permeability as well. Novel drug delivery systems are a successful strategies to overcome the low bioavailability issue, and redirect the native forms to CNS-targets. This work bridges a solid opinion over this hot topic of medicinal chemistry and natural products research.
Article
Sepsis-associated encephalopathy (SAE), a complication of sepsis, is often complicated by acute and long-term brain dysfunction. SAE is associated with electroencephalogram pattern changes and abnormal neuroimaging findings. The major processes involved are neuroinflammation, circulatory dysfunction, and excitotoxicity. Neuroinflammation and microcirculatory alterations are diffuse, whereas excitotoxicity might occur in more specific structures involved in the response to stress and the control of vital functions. A dysfunction of the brainstem, amygdala, and hippocampus might account for the increased mortality, psychological disorders, and cognitive impairment. This review summarizes clinical and paraclinical features of SAE and describes its mechanisms at cellular and structural levels.
Article
The comorbidity of current and lifetime DSM-IV anxiety and mood disorders was examined in 1,127 outpatients who were assessed with the Anxiety Disorders Interview Schedule for DSM-IV :Lifetime version (ADIS-IV-L). The current and lifetime prevalence of additional Axis I disorders in principal anxiety and mood disorders was found to be 57% and 81%, respectively. The principal diagnostic categories associated with the highest comorbidity rates were mood disorders, posttraumatic stress disorder (PTSD), and generalized anxiety disorder (GAD). A high rate of lifetime comorbidity was found between the anxiety and mood disorders; the lifetime association with mood disorders was particularly strong for PTSD, GAD, obsessive-compulsive disorder, and social phobia. The findings are discussed in regard to their implications for the classification of emotional disorders.